the FDA recently approved the new treatment for an eye disease.
the drug Jetrea... is being called a medical breakthrough.
NBC's Joelle Parks explains how it works.
Jetrea is finally here.
the drug to treat the debilitating eye disease- is now available for the public.
Dr. Alexander Eaton, ophthalmologist: "this drug is really a significant step forward, it's the first drug in its class so it's really unique."
Diane Keen knows the importance of this breakthrough.
Diane Keen, patient: "i can't do most things, i can't read, can't drive , sometimes it's hard to communicate if you can't see who you're talking to, so it's pretty important."
diane has vitreomacular adhesion or vma.
she'll will be one of the first in the united states... to receive the jetrea treatment for vma.
Dr. Alexander Eaton, ophthalmologist: "it's an adhesion between the gel in the eye and the retina, why some people get it and others don't i don't think we really know."
the adhesion causes pulling in the eye, which can be painful and lead to vision loss.
this drug- is the only option besides surgery to separate the gel and your retina.
jetera can also be used on patients with holes in their retina.
after numbing agents, it's injected directly into the eye.
jetrea either works- or it doesn't.
Dr. Alexander Eaton, ophthalmologist: "it may be that you're better within a few days, that's certainly very possible."
the possibilities- go beyond this room.
Diane Keen, patient: "it's exciting to be one of the first and hopefully other people will benefit."
the price is different for every patient because it's based on your specific health insurance plan.
for more information... contact your doctor.